Summary: A landmark study has found that cumulative lifetime exposure to lead is a major, often overlooked driver of dementia among older Americans. By estimating bone lead levels—which act as a long-term biological record of exposure—researchers discovered that people with the highest bone lead concentrations face nearly three times the risk of developing Alzheimer’s disease compared with those with the lowest levels.
This long-term burden of lead exposure is far more predictive than current blood lead measurements. Lead stored in the skeleton for decades can be released back into the bloodstream and travel to the brain as people age. The study estimates that roughly 18% of new dementia cases in the U.S. each year may be attributable to this historical environmental exposure.
Key Facts
- The Triple Risk: Individuals in the highest quarter of bone lead concentrations had a 2.96-fold higher risk of Alzheimer’s disease and a 2.15-fold higher risk of all-cause dementia compared with those in the lowest quarter.
- Bone vs. Blood: Blood lead only reflects recent exposure and does not reliably predict dementia risk. Bone lead persists for decades and provides a clearer measure of lifelong exposure that can contribute to chronic brain disease.
- The “Silent” Reservoir: Many adults born before 1980 carry a substantial legacy of lead exposure from leaded gasoline and lead-based paint. Age-related bone loss can mobilize this stored lead, allowing it to circulate and potentially reach the brain.
Source: University of Michigan
As dementia rates rise in the United States, research from the University of Michigan School of Public Health points to cumulative lead exposure as a significant environmental risk factor for Alzheimer’s disease and other dementias in older adults.
“This is the first empirical study to estimate that 18% of new dementia cases in the United States each year may be linked to cumulative lead exposure,” said Kelly Bakulski, associate professor of Epidemiology at Michigan Public Health and one of the study’s senior authors.
“With approximately half a million Americans diagnosed with dementia each year, an 18% attributable fraction corresponds to nearly 90,000 potentially preventable cases—an important and actionable public health signal,” Bakulski added.
Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the study found that participants with bone lead levels in the highest quartile had nearly three times the risk of Alzheimer’s disease (HR 2.96) and more than twice the risk of all-cause dementia (HR 2.15) compared with those in the lowest quartile. The results underline cumulative lead exposure as a key environmental contributor to dementia risk.
Cumulative exposure matters more than recent exposure
The research team used data from the National Health and Nutrition Examination Survey (NHANES) linked to Medicare claims and death records, with up to 30 years of follow-up. They applied machine learning methods to estimate patella and tibia bone lead concentrations, which serve as biomarkers of lifetime lead burden.
A central finding is that estimated bone lead was strongly associated with dementia outcomes, while current blood lead levels showed no consistent association. As Sung Kyun Park, professor of Epidemiology and Environmental Health Sciences and a senior author, explained, blood lead reflects recent exposure with a half-life of roughly 30 days, whereas bone lead can remain for years or decades—making bone lead a superior marker for cumulative exposure that may contribute to late-life neurodegenerative disease.
Most study participants were born before 1980, a period of substantially higher environmental lead contamination from sources such as leaded gasoline and lead-based paint. Xin Wang, the study’s first author and a research assistant professor in the Department of Epidemiology, noted that once lead becomes incorporated into bone it can remain for decades and later be released into circulation, especially with age-related bone loss. When mobilized, this stored lead can reach organs including the brain and contribute to neurodegenerative processes linked to Alzheimer’s disease.
The authors stress that removing remaining community lead sources—old paint, lead pipes, contaminated soil and industrial emissions—is crucial to protect current and future generations from accumulating a lifetime lead burden that may later manifest as cognitive decline or dementia.
Additional authors: Erika Walker, Roger Albin, and Henry Paulson of the University of Michigan; Bhramar Mukherjee of the Yale School of Public Health; and Hiroko Dodge of Massachusetts General Hospital and Harvard Medical School.
Funding/disclosures: The research was supported by the National Institute on Aging (R01 AG070897, K01 AG084821, and P30 AG072931) and the National Institute of Environmental Health Sciences (P30 ES017885).
Key Questions Answered:
A: Not necessarily. Blood lead tests reflect recent exposure over the past month or so. This study indicates that the more relevant risk comes from lead stored in bone from decades earlier—exposures that blood tests today may not reveal.
A: As people age, bone turnover increases and minerals stored in bone are released back into the bloodstream. Lead co-located in bone can be mobilized in that process and travel to the brain, where it may contribute to neurodegeneration associated with Alzheimer’s disease.
A: The study suggests that about 18% of annual dementia cases could be linked to cumulative lead exposure. While past exposure cannot be undone, reducing current environmental lead sources—such as old pipes, lead paint, and contaminated soil—can prevent new generations from accumulating the lifelong lead burden that elevates dementia risk.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The journal paper was reviewed in full.
- Additional context was added by staff to clarify public health implications.
About this environmental neuroscience and Alzheimer’s disease research news
Author: Destiny Cook
Source: University of Michigan
Contact: Destiny Cook – University of Michigan
Image: The image is credited to Neuroscience News
Original Research: Open access. “Exposure to lead and incidence of Alzheimer’s disease and all-cause dementia in the United States” by Xin Wang, Kelly M. Bakulski, Erika Walker, Bhramar Mukherjee, Hiroko Dodge, Roger L. Albin, Henry L. Paulson, Sung Kyun Park. Alzheimer’s & Dementia. DOI:10.1002/alz.71075
Abstract
Exposure to lead and incidence of Alzheimer’s disease and all-cause dementia in the United States
INTRODUCTION
Evidence is growing that lead exposure may raise dementia risk, but human studies are limited. This research examined prospective associations between lead exposure and incident Alzheimer’s disease (AD) and all-cause dementia in nationally representative U.S. populations.
METHODS
Baseline measured blood lead and estimated patella and tibia bone lead from NHANES-III (1988–1994; blood n = 6,217; bone n = 5,865) and continuous NHANES (1999–2016; blood n = 8,038; bone n = 4,824) were linked to Medicare and the National Death Index for incident AD and all-cause dementia with up to 30 years of follow-up. Survey-weighted Cox regression models estimated hazard ratios and 95% confidence intervals.
RESULTS
In continuous NHANES, estimated patella lead was associated with AD (HR = 2.96, 95% CI: 1.37–6.39) and all-cause dementia (HR = 2.15, 95% CI: 1.33–3.46) comparing the highest versus lowest quartiles. Associations were weaker in NHANES-III. Blood lead showed no association with dementia outcomes.
DISCUSSION
These findings indicate that cumulative lifetime lead exposure may be an important, yet underrecognized, environmental risk factor for Alzheimer’s disease and all-cause dementia, underscoring the public health value of ongoing lead remediation and prevention efforts.